Possibility
Explore our work: what we do, how we do it, and the value we create for our clients.
Impact
Culture
Possibility
Explore our work: what we do, how we do it, and the value we create for our clients.
Global Shifts
Empowered consumers
Healthier humans
Future organisations
Business for better
Safer societies
Sustainable world
Industries
Consumer and manufacturing
Defence and security
Energy and utilities
Financial services
Government and public sector
Health
Life sciences
Transport
Services
Set growth strategy
Build brands, products, and services
Reimagine AI, digital, and data
Improve organisational performance
Deliver complex programmes
Empower your people
Impact
Culture

Life sciences

Showing 21-30 of 207 results
Sort by:
Insight

Mobile health: policy and regulation for intelligent healthcare

Insight

What does open innovation mean to pharmaceutical R & D and how can it be realised?

Insight

Pharma and big data – the commercial opportunity

Big data can unlock the potential of existing medicines. By analysing data about their existing treatments, pharma companies have a real opportunity to prevent health problems that may be associated with the drugs.
Insight

10 simple rules for creating an effective portfolio of regulated documents

Insight

How to ensure a switch to sustainable materials is sustainable

Moving to sustainable materials isn’t a trivial task. There are scientific and engineering challenges, regulatory hurdles and a need to benchmark the green credentials of different materials. And organisations need to do all this without increasing cost or reducing performance.
Insight

Why it pays to prune patents

Interns at GITC
Insight

Preparing tomorrow’s problem solvers

PA's summer internship programme at our Global Innovation & Technology Centre in Cambridge, UK.
Interns at GITC
Insight

Building a positive human future with our summer interns

Insight

Rise to the biofilm challenge: harmful microbes present opportunities for innovators

Insight

CAR-T: Creating an effective IP strategy

Close examination of the rapidly evolving CAR-T patent landscape can inform an effective commercialisation strategy. This would include who has the best patents to invest in, which geographies are best to target and how to accelerate development of more effective manufacturing processes.